Reports
Sale
Philippines Dialysis Market Size, Share, Analysis, Report: By Type: Hemodialysis, Peritoneal Dialysis; By Product & Services: Equipment, Consumables, Dialysis Drugs, Services; By End User: In Center Dialysis, Home Dialysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Model, Key Demand Indicators; Supplier Landscape; 2024-2032
Philippines Dialysis Market Outlook
The Philippines dialysis market size is expected to grow at a CAGR of 5.2% during the forecast period of 2024-2032, driven by the increasing incidence of chronic kidney disease and improvements in healthcare infrastructure across the region.
Philippines Dialysis Market Overview
Chronic kidney disease (CKD) is a major public health burden with a prevalence rate of 9.1%-13.4% worldwide. In Philippines, the prevalence rate stands at 35.94%, significantly higher than the global rates. Consequently, the incidence of dialysis procedures is also on the rise. Around 94% of the patients affected from end stage renal disease undergo center-based hemodialysis, whereas 4% are on peritoneal dialysis and 2% of the people undergo kidney transplantation. Hemodialysis is the most preferred treatment alternative, owing to its cost effectiveness.
Philippines dialysis market growth is driven by the increasing healthcare investments to improve the infrastructure and facilities for healthcare services across the country. Technical advancements to enhance efficiency, safety, and patient outcomes, along with a preference for portable dialysis is another significant market trend. In addition, rising partnerships between public and private authorities are expected to fuel the market value in the forecast period.
Growth in Infrastructure Improvement Activities
To facilitate affordable and technically advanced medical solutions, the Filipino government has allocated a substantial healthcare budget. This has led to significant improvements in the infrastructure, boosting the Philippines dialysis market share. In October 2023, the National Economic and Development Authority (NEDA) Board approved the Dialysis Centre PPP project. The new project is aimed at upgrading the Renal Center Facility of the Baguio General Hospital and Medical Center (BGHMC) by setting up a fully operational dialysis center at the location. Making hemodialysis accessible to more patients has been a key agenda of the new setup.
Rising Prevalence for Home-based Solutions to Meet the Growing Philippines Dialysis Market Demand
With a surge in technical advancements, the market has been witnessing multiple innovative solutions to offer convenient and advanced care to patients. As a result, the advent of at-home portable dialyzers is a major market trend. In October 2023, Quanta Dialysis Technologies revealed that their portable at home dialysis system, titled Quanta™ Dialysis System proved to be successful in the Home Run™ study. When compared to larger, traditional machines, the new system offered versatility and was fit to be used in multiple settings. Enabled with an intuitive user interface, it can be directly used by patients.
The prevalence for portable dialysis systems is a major market trend expected to impact the developed as well as developing countries. Consequently, the Philippines dialysis market size is poised to grow as the region expedites their efforts to improve infrastructure and bring the latest technologies for the consumers.
Increased Collaborations to Offer Early Diagnosis and Cost-Effective Services
In December 2023, the Department of the Interior and Local Government (DILG), collaborated with AstraZeneca t o offer free testing for people who might be suffering from chronic kidney disease. Launching the ACT NOW program, the 12 provincial governments aim to mitigate the rising incidence of chronic illness and educate the population with relevant information. The awareness campaign will span across major Filipino provinces including Quirino, Aurora, Cavite, Quezon, Sorsogon, Samar, Capiz, Iloilo, Cebu, Zamboanga del Norte, Agusan del Sur, and Sarangani, wherein around one million Filipinos can get free access to free Urine Albumin Creatinine Ratio (UACR) test. Early detection of CKD can help in providing appropriate treatment alternatives to the patients.
Philippines Dialysis Market Segmentation
Market Breakup by Type
- Hemodialysis
- Conventional Hemodialysis
- Short Daily Hemodialysis
- Nocturnal Hemodialysis
- Peritoneal Dialysis
- Continuous Ambulatory Peritoneal Dialysis
- Automated Peritoneal Dialysis
Market Breakup by Product & Services
- Equipment
- Dialysis Machines
- Water Treatment Systems
- Others
- Consumables
- Dialyzers
- Catheters
- Others
- Dialysis Drugs
- Services
Market Breakup by End User
- In Center Dialysis
- Home Dialysis
Philippines Dialysis Market Regional Analysis
In June 2023, the Philippine Health Insurance Corporation (PhilHealth) announced the expansion of their hemodialysis coverage from 90 to 156 sessions for the patients. It allows a patient to avail 3 sessions per week for a year, paying around P405,600 per year (only P2,600 per session). With economic growth and rising government emphasis on the medical sector, the region has been substantial market growth.
Manila and the national capital region as poised to lead the Philippines dialysis market share, which can be accredited to increasing initiatives aimed at boosting the infrastructure. In addition, Philippines has become a major medical tourism attraction amongst people seeking pocket-friendly healthcare services, including dialysis treatment. The country’s premium medical services, made available at an affordable price, bring plenty of foreign investments, impacting the growth of dialysis market as well.
There have been continuous efforts to enhance the quality of services on a rural level, so as to facilitate high-quality services to the marginalized communities as well.
Philippines Dialysis Market: Competitor Landscape
In April 2023, Medtronic partnered with DaVita to launch Mozarc Medical, an independent company focused at improving kidney health and associated solutions for patients. The company seeks to improve the home dialysis scenario by allowing ease of application, clinical performance, and accessibility for the patients. Focusing on innovative and meaningful kidney health technologies, the new company aims to increase access to quality treatment globally. The establishment of the new company is a testament of rising emphasis on combating kidney associated morbidities across the globe. Several prominent companies are joining forces to expand their product portfolios.
The key features of the Philippines dialysis market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Fresenius SE & Co. KGaA
- Asahi Kasei Corporation
- B. Braun SE
- Baxter
- BD
- DaVita Inc.
- AngioDynamics
- Diaverum Deutschland Gmbh
- Nikkiso Co., Ltd.
- Nipro
- Hemotek
- Nepro Group Dialysis Center
- Dialife Group
- Medtronic
- NxStage Medical, Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Product & Services |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Philippines Dialysis Market Overview
3.1 Philippines Dialysis Market Historical Value (2017-2023)
3.2 Philippines Dialysis Market Forecast Value (2024-2032)
4 Philippines Dialysis Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.2.1 Strengths
4.2.2 Weaknesses
4.2.3 Opportunities
4.2.4 Threats
4.3 Porter’s Five Forces Model
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Power of Buyers
4.3.3 Threat of New Entrants
4.3.4 Threat of Substitutes
4.3.5 Degree of Rivalry
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Philippines Dialysis Market Segmentation
5.1 Philippines Dialysis Market by Type
5.1.1 Market Overview
5.1.2 Hemodialysis
5.1.2.1 Conventional Hemodialysis
5.1.2.2 Short Daily Hemodialysis
5.1.2.3 Nocturnal Hemodialysis
5.1.3 Peritoneal Dialysis
5.1.3.1 Continuous Ambulatory Peritoneal Dialysis
5.1.3.2 Automated Peritoneal Dialysis
5.2 Philippines Dialysis Market by Product & Services
5.2.1 Market Overview
5.2.2 Equipment
5.2.2.1 Dialysis Machines
5.2.2.2 Water Treatment Systems
5.2.2.3 Others
5.2.3 Consumables
5.2.3.1 Dialyzers
5.2.3.2 Catheters
5.2.3.3 Others
5.2.4 Dialysis Drugs
5.2.5 Services
5.3 Philippines Dialysis Market by End User
5.3.1 Market Overview
5.3.2 In Center Dialysis
5.3.3 Home Dialysis
6 Patent Analysis
6.1 Analysis by Type of Patent
6.2 Analysis by Publication Year
6.3 Analysis by Issuing Authority
6.4 Analysis by Patent Age
6.5 Analysis by CPC Analysis
6.6 Analysis by Patent Valuation
6.7 Analysis by Key Players
7 Grants Analysis
7.1 Analysis by Year
7.2 Analysis by Amount Awarded
7.3 Analysis by Issuing Authority
7.4 Analysis by Grant Application
7.5 Analysis by Funding Institute
7.6 Analysis by NIH Departments
7.7 Analysis by Recipient Organization
8 Funding Analysis
8.1 Analysis by Funding Instances
8.2 Analysis by Type of Funding
8.3 Analysis by Funding Amount
8.4 Analysis by Leading Players
8.5 Analysis by Leading Investors
8.6 Analysis by Geography
9 Partnership and Collaborations Analysis
9.1 Analysis by Partnership Instances
9.2 Analysis by Type of Partnership
9.3 Analysis by Leading Players
9.4 Analysis by Geography
10 Regulatory Framework
10.1 Regulatory Overview
11 Supplier Landscape
11.1 Fresenius SE & Co. KGaA
11.1.1 Financial Analysis
11.1.2 Product Portfolio
11.1.3 Demographic Reach and Achievements
11.1.4 Mergers and Acquisitions
11.1.5 Certifications
11.2 Asahi Kasei Corporation
11.2.1 Financial Analysis
11.2.2 Product Portfolio
11.2.3 Demographic Reach and Achievements
11.2.4 Mergers and Acquisitions
11.2.5 Certifications
11.3 B. Braun SE
11.3.1 Financial Analysis
11.3.2 Product Portfolio
11.3.3 Demographic Reach and Achievements
11.3.4 Mergers and Acquisitions
11.3.5 Certifications
11.4 Baxter
11.4.1 Financial Analysis
11.4.2 Financial Portfolio
11.4.3 Demographic Reach and Achievements
11.4.4 Mergers and Acquisitions
11.4.5 Certifications
11.5 BD
11.5.1 Financial Analysis
11.5.2 Product Portfolio
11.5.3 Demographic Reach and Achievements
11.5.4 Mergers and Acquisitions
11.5.5 Certifications
11.6 DaVita Inc.
11.6.1 Financial Analysis
11.6.2 Product Portfolio
11.6.3 Demographic Reach and Achievements
11.6.4 Mergers and Acquisitions
11.6.5 Certifications
11.7 AngioDynamics
11.7.1 Financial Analysis
11.7.2 Product Portfolio
11.7.3 Demographic Reach and Achievements
11.7.4 Mergers and Acquisitions
11.7.5 Certifications
11.8 Diaverum Deutschland Gmbh
11.8.1 Financial Analysis
11.8.2 Product Portfolio
11.8.3 Demographic Reach and Achievements
11.8.4 Mergers and Acquisitions
11.8.5 Certifications
11.9 Nikkiso Co., Ltd.
11.9.1 Financial Analysis
11.9.2 Product Portfolio
11.9.3 Demographic Reach and Achievements
11.9.4 Mergers and Acquisitions
11.9.5 Certifications
11.10 Nipro
11.10.1 Financial Analysis
11.10.2 Product Portfolio
11.10.3 Demographic Reach and Achievements
11.10.4 Mergers and Acquisitions
11.10.5 Certifications
11.11 Hemotek
11.11.1 Financial Analysis
11.11.2 Product Portfolio
11.11.3 Demographic Reach and Achievements
11.11.4 Mergers and Acquisitions
11.11.5 Certifications
11.12 Nepro Group Dialysis Center
11.12.1 Financial Analysis
11.12.2 Product Portfolio
11.12.3 Demographic Reach and Achievements
11.12.4 Mergers and Acquisitions
11.12.5 Certifications
11.13 Dialife Group
11.13.1 Financial Analysis
11.13.2 Product Portfolio
11.13.3 Demographic Reach and Achievements
11.13.4 Mergers and Acquisitions
11.13.5 Certifications
11.14 Medtronic
11.14.1 Financial Analysis
11.14.2 Product Portfolio
11.14.3 Demographic Reach and Achievements
11.14.4 Mergers and Acquisitions
11.14.5 Certifications
11.15 NxStage Medical, Inc.
11.15.1 Financial Analysis
11.15.2 Product Portfolio
11.15.3 Demographic Reach and Achievements
11.15.4 Mergers and Acquisitions
11.15.5 Certifications
12 Philippines Dialysis Market - Distribution Model (Additional Insight)
12.1 Overview
12.2 Potential Distributors
12.3 Key Parameters for Distribution Partner Assessment
13 Key Opinion Leaders (KOL) Insights (Additional Insight)
14 Company Competitiveness Analysis (Additional Insight)
14.1 Very Small Companies
14.2 Small Companies
14.3 Mid-Sized Companies
14.4 Large Companies
14.5 Very Large Companies
15 Payment Methods (Additional Insight)
15.1 Government Funded
15.2 Private Insurance
15.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market is anticipated to grow at a CAGR of 5.2% during the forecast period of 2024-2032, driven by the rising incidence of chronic kidney disease and growing healthcare infrastructure across the region.
The market demand is driven by technical advancements in the dialysis systems including preference for at home, portable dialysis systems, as well as increased availability of affordable and accessible treatment options.
The establishment of new dialysis centres, fit to accommodate all latest advancements is a major market trend. In October 2023, the National Economic and Development Authority (NEDA) Board approved the Dialysis Centre PPP project to upgrade the Renal Center Facility of the Baguio General Hospital and Medical Center (BGHMC).
Based on types, the market is divided into hemodialysis and peritoneal dialysis. Hemodialysis is further segmented into conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis while peritoneal dialysis includes continuous ambulatory peritoneal dialysis along with automated peritoneal dialysis.
Major end users include in-center dialysis and home dialysis.
They are broadly divided into equipment, consumables, dialysis drugs and services. Equipment includes dialysis machines and water treatment systems among others, while consumables are further segmented into dialyzers, catheters, and others.
Key players involved in the market are Fresenius SE & Co. KGaA, Asahi Kasei Corporation, B. Braun SE, Baxter, BD, DaVita Inc., AngioDynamics, Diaverum Deutschland Gmbh, Nikkiso Co., Ltd., Nipro, Hemotek, Nepro Group Dialysis Center, Dialife Group, Medtronic and NxStage Medical, Inc.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2199
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 3299
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 4399
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 5499
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER